Search research articles
Contact Us
Filters
Showing results (161-170 of 181) with videos related to
Page
of 19
Sort By:
Videogie : an Official Video Journal of the American Society for Gastrointestinal Endoscopy
|
May 9, 2019
Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience
Manoop S Bhutani, Irina M Cazacu, Alexandra A Luzuriaga Chavez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
Aparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.
Cancers
|
October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid Tumors
Vivek Subbiah, William Erwin, Osama Mawlawi, et al.
Nature Medicine
|
March 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Zev A Wainberg, Gulam A Manji, Nathan Bahary, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 17, 2025
KRAS <sup>G12D</sup> -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients
Valerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan, et al.
Cancer Cell
|
November 14, 2018
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8<sup>+</sup> T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Aung Naing, Jeffrey R Infante, Kyriakos P Papadopoulos, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Mingxuan Xu, Coya Tapia, Joud Hajjar, et al.
The Journal of Clinical Investigation
|
October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
Ya'an Kang, Jenying Deng, Jianhua Ling, et al.
Future Oncology (London, England)
|
August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding, Jia Fan, Do-Youn Oh, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 181) with videos related to
Sort By:
Page
of 19
Videogie : an Official Video Journal of the American Society for Gastrointestinal Endoscopy
|
May 9, 2019
Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience
Manoop S Bhutani, Irina M Cazacu, Alexandra A Luzuriaga Chavez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
Aparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.
Cancers
|
October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid Tumors
Vivek Subbiah, William Erwin, Osama Mawlawi, et al.
Nature Medicine
|
March 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Zev A Wainberg, Gulam A Manji, Nathan Bahary, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 17, 2025
KRAS <sup>G12D</sup> -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients
Valerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan, et al.
Cancer Cell
|
November 14, 2018
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8<sup>+</sup> T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Aung Naing, Jeffrey R Infante, Kyriakos P Papadopoulos, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens
Mingxuan Xu, Coya Tapia, Joud Hajjar, et al.
The Journal of Clinical Investigation
|
October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
Ya'an Kang, Jenying Deng, Jianhua Ling, et al.
Future Oncology (London, England)
|
August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding, Jia Fan, Do-Youn Oh, et al.
Page
of 19